Acurx Pharmaceuticals, Inc. (ACXP)
1.48
-0.05
(-3.27%)
USD |
NASDAQ |
Mar 03, 16:00
1.49
+0.01
(+0.68%)
After-Hours: 20:00
Acurx Pharmaceuticals Free Cash Flow : -7.853M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Adial Pharmaceuticals, Inc. | -6.622M |
| ACADIA Pharmaceuticals, Inc. | 6.308M |
| Alnylam Pharmaceuticals, Inc. | 465.38M |
| Savara, Inc. | -99.27M |
| BioMarin Pharmaceutical, Inc. | 717.02M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.881M |
| Cash from Financing (Quarterly) | 1.724M |
| Free Cash Flow Per Share (Quarterly) | -1.157 |
| Free Cash Flow to Equity (Quarterly) | -1.881M |
| Free Cash Flow to Firm (Quarterly) | -1.881M |
| Free Cash Flow Yield | -89.54% |